WG
ASTH icon

Winton Group’s Astrana Health ASTH Stock Holding History

Winton Group’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,377
Closed -$233K – 1075
2025
Q2 		$233K Buy
+9,377
New +$264K 0.01% 726
2021
Q4 		– Sell
-17,813
Closed -$1.62M – 1456
2021
Q3 		$1.62M Sell
17,813
-4,474
-20% -$380K 0.09% 281
2021
Q2 		$1.4M Buy
22,287
+2,446
+12% +$90.4K 0.08% 341
2021
Q1 		$537K Buy
19,841
+1,944
+11% +$46.8K 0.03% 846
2020
Q4 		$327K Sell
17,897
-14,161
-44% -$255K 0.02% 1002
2020
Q3 		$575K Buy
32,058
+1,371
+4% +$23.7K 0.02% 1055
2020
Q2 		$506K Buy
30,687
+3,472
+13% +$54.6K 0.01% 1174
2020
Q1 		$352K Sell
27,215
-16,227
-37% -$265K 0.01% 1127
2019
Q4 		$800K Buy
43,442
+21,986
+102% +$365K 0.01% 1117
2019
Q3 		$378K Buy
+21,456
New +$367K ﹤0.01% 1182

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Winton Group's ASTH Position: Q3 2025 in Review

Winton Group sold out of Astrana Health (ASTH) in Q3 2025, closing a stake of 9,377 shares — an estimated $233K sold.

Winton Group first reported a position in ASTH in Q3 2019 and held it in 10 quarters. The position peaked at $1.62M in Q3 2021. 188 funds tracked by Wall St. Rank hold ASTH as of Q3 2025.

  • Winton Group reported no remaining Astrana Health position as of Q3 2025 after selling out during the quarter.
  • Winton Group sold 9,377 Astrana Health shares in Q3 2025, an estimated $233K.
  • Winton Group first reported a position in Astrana Health in Q3 2019 and held it in 10 quarters.
  • Winton Group's Astrana Health position peaked at $1.62M in Q3 2021.
  • 188 funds tracked by Wall St. Rank held Astrana Health as of Q3 2025.

Based on Winton Group's 13F filing for Q3 2025, filed 13 Nov 2025.